140 related articles for article (PubMed ID: 6366806)
1. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
Jaffé G; Grimshaw JJ
Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
[TBL] [Abstract][Full Text] [Related]
2. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.
Pasotti C; Capra A; Vibelli C
Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):176-80. PubMed ID: 376459
[TBL] [Abstract][Full Text] [Related]
3. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
Baronti A; Grieco A; Vibelli C
Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
[TBL] [Abstract][Full Text] [Related]
4. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
Baronti A; Grieco A; Vibelli C
Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
[TBL] [Abstract][Full Text] [Related]
5. A trial of clenbuterol in bronchial asthma.
Anderson G; Wilkins E
Thorax; 1977 Dec; 32(6):717-9. PubMed ID: 341407
[TBL] [Abstract][Full Text] [Related]
6. [Novel quantitative assessment of the tremorogenic effects of the beta 2-mimetics clenbuterol and salbutamol after oral administration].
Schaffler K; Schuster D
Arzneimittelforschung; 1985; 35(8):1299-302. PubMed ID: 3907640
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of clenbuterol and salbutamol in the clinical control of the intercritical period in patients with recurrent bronchial asthma].
Castelán Montalvo FA; Martínez Hernández G; Palmeros L
Rev Alerg Mex (1987); 1989; 36(1):28-30. PubMed ID: 2749126
[No Abstract] [Full Text] [Related]
8. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
Dyson AJ; Mackay AD
Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
[TBL] [Abstract][Full Text] [Related]
9. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
[TBL] [Abstract][Full Text] [Related]
10. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
Ulmer WT; Scholz HJ; Baines A
Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
[TBL] [Abstract][Full Text] [Related]
11. Comparison of NAB 365 and salbutamol tablets in chronic bronchitis and asthma.
Cummiskey J; Keelan P; Gray P; Cox GA
Ir Med J; 1978 Mar; 71(4):123-6. PubMed ID: 344272
[No Abstract] [Full Text] [Related]
12. Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.
Papiris S; Galavotti V; Sturani C
Respiration; 1986; 49(2):101-8. PubMed ID: 3513269
[TBL] [Abstract][Full Text] [Related]
13. First clinical studies on mabuterol. A summarizing report.
Kawakami Y
Arzneimittelforschung; 1984; 34(11A):1699-700. PubMed ID: 6152166
[TBL] [Abstract][Full Text] [Related]
14. Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol).
Brusasco V; Vibelli C; Chierichetti S; Ramoino R
Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):589-93. PubMed ID: 365800
[TBL] [Abstract][Full Text] [Related]
15. A clinical trial of oral clenbuterol (NAB 365) in chronic airways obstruction.
Brusasco V; Crimi E; Mangini S; Vibelli C
Curr Med Res Opin; 1980; 6(7):449-55. PubMed ID: 6988173
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of bronchodilation in chronic reversible airways obstruction. Comparison between choline theophyllinate and salbutamol.
Tanser AR
Practitioner; 1982 Mar; 226(1365):569-71. PubMed ID: 7045848
[No Abstract] [Full Text] [Related]
17. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
[TBL] [Abstract][Full Text] [Related]
18. [Placebo-controlled comparative study of clenbuterol and terbutaline in asthmatic children].
Valente Mérida J; Medina J
Rev Alerg Mex (1987); 1989; 36(2):61-4. PubMed ID: 2665027
[TBL] [Abstract][Full Text] [Related]
19. [Tocolysis with clenbuterol tablets].
Kovács L; Mészáros G; Pál A; Szász K
Zentralbl Gynakol; 1987; 109(22):1368-73. PubMed ID: 3324563
[TBL] [Abstract][Full Text] [Related]
20. The effects of nebulized salbutamol on lung function and exercise tolerance in patients with severe airflow obstruction.
Connellan SJ; Gough SE
Br J Dis Chest; 1982 Apr; 76(2):135-42. PubMed ID: 7093130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
